Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Stuck

<< Previous

Bullboard Posts

Next >>

Comment by clutchbeyerson Feb 16, 2021 12:45pm

193 Views

Post# 32574317

RE:Stuck

woundedknee wrote:
We may be spinning our wheels here for a while. But things can change quickly...like a 2 billion buyout. Management needs to keep dropping little tid bits. Even if one had oatmeal for breakfast.

If they agree to a 2bil buyout then the pouch isn't much of anything special. Having the device that harnesses a potential cure for Type 1 and other blood diseases would not be bought for 2bil. Unless they are having varying degress of success in their human trials and dont have the immune protection figured out...

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property